London biotech firm to fund growth with cap hike
UK biotech firm Retroscreen Virology on Wednesday raised £33.6m through a sale of shares to new and existing investors that will allow the firm to fund its upcoming projects.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts